VANGUARD GROUP INC - INTEGRA LIFESCIENCES HLDGS C ownership

INTEGRA LIFESCIENCES HLDGS C's ticker is IART and the CUSIP is 457985208. A total of 255 filers reported holding INTEGRA LIFESCIENCES HLDGS C in Q4 2020. The put-call ratio across all filers is 1.05 and the average weighting 0.1%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of INTEGRA LIFESCIENCES HLDGS C
ValueSharesWeighting
Q3 2023$273,434,824
-6.2%
7,159,854
+1.0%
0.01%0.0%
Q2 2023$291,511,342
-27.7%
7,087,560
+0.9%
0.01%
-30.0%
Q1 2023$403,329,535
+0.6%
7,025,423
-1.7%
0.01%
-9.1%
Q4 2022$400,774,848
+36.5%
7,147,759
+3.1%
0.01%
+22.2%
Q3 2022$293,538,000
-19.4%
6,929,606
+2.8%
0.01%
-10.0%
Q2 2022$364,153,000
-13.5%
6,739,834
+2.8%
0.01%0.0%
Q1 2022$421,167,000
-5.6%
6,554,107
-1.6%
0.01%0.0%
Q4 2021$446,094,000
-2.4%
6,659,122
-0.2%
0.01%
-9.1%
Q3 2021$456,925,000
+0.7%
6,672,386
+0.3%
0.01%0.0%
Q2 2021$453,899,000
-0.6%
6,651,498
+0.7%
0.01%
-8.3%
Q1 2021$456,509,000
+8.6%
6,607,448
+2.1%
0.01%0.0%
Q4 2020$420,328,000
+39.5%
6,474,541
+1.5%
0.01%
+20.0%
Q3 2020$301,308,000
-4.0%
6,380,970
-4.5%
0.01%
-9.1%
Q2 2020$314,018,000
+2.9%
6,682,658
-2.2%
0.01%
-15.4%
Q1 2020$305,256,000
-21.2%
6,833,587
+2.7%
0.01%0.0%
Q4 2019$387,602,000
-5.0%
6,650,699
-2.1%
0.01%
-13.3%
Q3 2019$408,109,000
+13.5%
6,793,883
+5.5%
0.02%
+7.1%
Q2 2019$359,626,000
+2.5%
6,439,137
+2.3%
0.01%0.0%
Q1 2019$350,757,000
+25.4%
6,295,015
+1.5%
0.01%
+7.7%
Q4 2018$279,701,000
-30.6%
6,201,810
+1.4%
0.01%
-18.8%
Q3 2018$403,070,000
-0.6%
6,119,189
-2.8%
0.02%
-5.9%
Q2 2018$405,304,000
+22.1%
6,292,579
+4.9%
0.02%
+13.3%
Q1 2018$331,866,000
+17.5%
5,996,873
+1.7%
0.02%
+25.0%
Q4 2017$282,332,000
-1.5%
5,899,122
+3.9%
0.01%
-7.7%
Q3 2017$286,660,000
-4.3%
5,678,690
+3.3%
0.01%
-13.3%
Q2 2017$299,526,000
+25.7%
5,494,894
-2.8%
0.02%
+25.0%
Q1 2017$238,289,000
+6.4%
5,656,048
+116.7%
0.01%0.0%
Q4 2016$223,875,000
+7.6%
2,609,560
+3.5%
0.01%0.0%
Q3 2016$208,063,000
+8.3%
2,520,453
+4.7%
0.01%0.0%
Q2 2016$192,111,000
+25.4%
2,408,001
+5.9%
0.01%
+20.0%
Q1 2016$153,191,000
+2.1%
2,274,226
+2.8%
0.01%0.0%
Q4 2015$150,001,000
-41.5%
2,213,062
-48.6%
0.01%0.0%
Q3 2015$256,496,000
+100.6%
4,307,270
+126.9%
0.01%
+11.1%
Q2 2015$127,883,000
+20.6%
1,898,233
+10.3%
0.01%
+28.6%
Q1 2015$106,066,000
+20.5%
1,720,456
+6.0%
0.01%
+16.7%
Q4 2014$87,988,000
+12.2%
1,622,485
+2.7%
0.01%0.0%
Q3 2014$78,387,000
+7.6%
1,579,111
+2.0%
0.01%0.0%
Q2 2014$72,830,000
+4.9%
1,547,599
+2.5%
0.01%0.0%
Q1 2014$69,433,000
+1.8%
1,509,724
+5.7%
0.01%0.0%
Q4 2013$68,173,000
+37.7%
1,428,911
+16.2%
0.01%
+20.0%
Q3 2013$49,504,000
+14.7%
1,229,921
+4.4%
0.01%0.0%
Q2 2013$43,153,0001,178,0850.01%
Other shareholders
INTEGRA LIFESCIENCES HLDGS C shareholders Q4 2020
NameSharesValueWeighting ↓
Champlain Investment Partners, LLC 5,473,820$305,001,0002.66%
FALCON POINT CAPITAL, LLC 80,729$4,498,0002.45%
Tributary Capital Management, LLC 508,838$28,352,0002.06%
Broadfin Capital, LLC 141,572$7,888,0001.63%
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income 182,585$10,174,0001.57%
Sapience Investments, LLC 132,810$7,400,0000.98%
VAUGHAN NELSON INVESTMENT MANAGEMENT, L.P. 1,110,177$61,860,0000.83%
Bellevue Group AG 222,350$12,389,0000.68%
Capital International Sarl 74,325$4,141,0000.52%
Hood River Capital Management LLC 180,772$10,073,0000.51%
View complete list of INTEGRA LIFESCIENCES HLDGS C shareholders